These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evidence that intrathymic islet transplantation does not prevent diabetes or subsequent islet graft destruction in RT6-depleted, diabetes-resistant BioBreeding/Worcester rats. Battan R; Mordes JP; Abreau S; Greiner DL; Handler ES; Rossini AA Transplantation; 1994 Mar; 57(5):731-6. PubMed ID: 8140636 [TBL] [Abstract][Full Text] [Related]
6. Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Posselt AM; Barker CF; Friedman AL; Naji A Science; 1992 May; 256(5061):1321-4. PubMed ID: 1598576 [TBL] [Abstract][Full Text] [Related]
7. Suppression of diabetes incidence by intrathymic islet isografting in newborn NOD mice. Nomura Y; Stein E; Mullen Y Transplant Proc; 1992 Dec; 24(6):2903. PubMed ID: 1465992 [No Abstract] [Full Text] [Related]
8. Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Sempé P; Ezine S; Marvel J; Bédossa P; Richard MF; Bach JF; Boitard C Int Immunol; 1993 May; 5(5):479-89. PubMed ID: 8318452 [TBL] [Abstract][Full Text] [Related]
9. Prevention of diabetes in BB/Wor rats by intrathymic islet injection. Koevary SB; Blomberg M J Clin Invest; 1992 Feb; 89(2):512-6. PubMed ID: 1737841 [TBL] [Abstract][Full Text] [Related]
10. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391 [TBL] [Abstract][Full Text] [Related]
11. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens. Cetkovic-Cvrlje M; Gerling IC; Muir A; Atkinson MA; Elliott JF; Leiter EH Diabetes; 1997 Dec; 46(12):1975-82. PubMed ID: 9392483 [TBL] [Abstract][Full Text] [Related]
12. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Chosich N; Harrison LC Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738 [TBL] [Abstract][Full Text] [Related]
13. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens. Leijon K; Hillörn V; Bergqvist I; Holmberg D J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996 [TBL] [Abstract][Full Text] [Related]
14. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Oluwole OO; Depaz HA; Gopinathan R; Ali A; Garrovillo M; Jin MX; Hardy MA; Oluwole SF Diabetes; 2001 Jul; 50(7):1546-52. PubMed ID: 11423475 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of tolerance induction after intrathymic islet injection: determination of the fate of alloreactive thymocytes. Turvey SE; Hara M; Morris PJ; Wood KJ Transplantation; 1999 Jul; 68(1):30-9. PubMed ID: 10428263 [TBL] [Abstract][Full Text] [Related]
16. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice. Gerling IC; Atkinson MA; Leiter EH J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041 [TBL] [Abstract][Full Text] [Related]
17. Induction of peripheral tolerance by intrathymic inoculation of soluble alloantigens: evidence for the role of host antigen-presenting cells and suppressor cell mechanism. Oluwole SF; Jin MX; Chowdhury NC; Engelstad K; Ohajekwe OA; James T Cell Immunol; 1995 Apr; 162(1):33-41. PubMed ID: 7704908 [TBL] [Abstract][Full Text] [Related]